BMO cuts ServiceNow stock price target on organic growth outlook By Investing.com

The first-order read is slower organic momentum, but the more important second-order issue is valuation reset risk in a stock that was still being priced for durable 20%+ compound growth. If current performance obligations decelerate while AI positioning remains more narrative than monetizable, the multiple can compress further before fundamentals stabilize. That creates a gap between “good business” and “good stock” that may persist for several quarters.

The near-term catalyst path is asymmetric to the downside because guidance revisions tend to matter more than headline beats for high-duration software names. Delayed enterprise deals, especially in longer-cycle geographies, can roll through backlog conversion with a lag of one to two quarters, so this is not just a one-print issue. If management can re-accelerate organic cRPO on the next two calls, the stock can retrace sharply; if not, the street will likely continue to ratchet down targets and de-rate the multiple.

Competitively, this is a relative rather than absolute opportunity. Large workflow software peers with clearer monetization of AI and less M&A noise should outperform on a “quality of growth” basis, while NOW may underperform until investors see evidence that AI is adding incremental deal velocity rather than just messaging support. The contrarian view is that the drawdown may already be discounting most of the bad news; however, with estimates still vulnerable, a cheap-looking valuation can remain a trap if organic growth keeps stepping down.